U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  1. Drugs

News & Events for Human Drugs

What's New?

Events

Meetings, Conferences, and Workshops

Sponsored or co-sponsored by FDA's Center for Drug Evaluation and Research (CDER)

Podcasts

Q&A with FDA Podcast Image

Q&A with FDA

Engaging conversation and discussion about the latest regulatory topics

FDA Drug Safety Podcast Graphic

FDA Drug Safety Podcasts

Emerging safety information about drugs in conjunction with the release of Drug Safety Communications

FDA DISCO Podcast Image Unbranded

Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

Information about current topics in cancer drug development

CDER Small Business & Industry Assistance (SBIA) Chronicles

CDER SBIA Chronicles

Useful information for industry to assist in all aspects of drug marketing and regulation


Sub-Topic Paragraphs

Features

CDER Conversation Graphic

CDER Conversations

Discussions with key CDER leadership about important regulatory and policy issues
Dark blue graphic with text overlay that reads "From Our Perspective" on the right of the graphic. On the left is an image of a vortex.

From Our Perspective

An insider's look at changes, initiatives and advances in drug development, review, and approval
Hexagon with small medical icons inside of it

Spotlight on CDER Science

CDER Scientists describe scientific advancements aimed at improving drug development
CDER Things to Know About series graphic

Things to Know About...

Fast facts about CDER's efforts and actions

Popular Topics

Novel Drugs at FDA

CDER’s New Molecular Entities and New Therapeutic Biological Products

FDA Newsroom

The latest news and events at the U.S. Food and Drug Administration (FDA)

Center

Recently published Drug-related Guidances

Drugs Databases

Drugs@FDA

Find information about most FDA-approved prescription, generic, and over-the-counter drug products

FDA Drug Shortages Database

Find information about drug shortages caused by manufacturing and quality problems, delays, and discontinuations

Orange Book

The Orange Book identifies drug products approved by FDA on the basis of safety and effectiveness

Paragraph Header
Contact FDA

Contact Point
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993

druginfo@fda.hhs.gov

Toll Free
(855) 543-3784
(301) 796-3400

Hours Available

CDER Division of Drug Information

For Latest Updates Follow

Contact Point Twitter

@FDA_Drug_Info

Your source for the latest drug information.
Know the moment it happens.


Subscribe to What's New Related to Drugs

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top